Format

Send to

Choose Destination
Eur Neurol. 2018;79(1-2):108-112. doi: 10.1159/000486755. Epub 2018 Feb 8.

Portuguese Observational Study of Ischaemic Stroke in Patients Medicated with Non-Vitamin K Antagonist Oral Anticoagulants.

Author information

1
Department of Neurology, Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal.
2
Department of Neurology, Hospital Egas Moniz, Centro Hospitalar Lisboa Ocidental, Lisboa, Portugal.
3
Department of Neurology, Hospital de Braga, Braga, Portugal.
4
Department of Neurology, Centro Hospitalar São João, Porto, Portugal.

Abstract

INTRODUCTION:

Clinical trials and subsequent meta-analyses showed advantages of non-vitamin K antagonists oral anticoagulants (NOACs) over vitamin K antagonists (VKAs) in patients with non-valvular atrial fibrillation. The impact of preadmission anticoagulation in acute ischaemic stroke (AIS) has not been established.

OBJECTIVE:

To compare functional outcome of patients with AIS with preadmission NOACs vs. VKAs.

METHODS:

A retrospective analysis was conducted on consecutive AIS patients under oral anticoagulation (VKAs or NOACs) admitted in 4 Portuguese hospitals within a period of 30 months. Two primary outcomes were defined and compared between VKA and NOAC groups: symptomatic intracerebral hemorrhage transformation (sICH) and modified Rankin Scale (mRS) at 3 months.

RESULTS:

Four hundred sixty-nine patients were included, of whom 332 (70.8%) were treated with VKA and 137 (29.2%) with NOAC. Patients' median age was 78.0 and 234 (49.9%) were male. NOAC-treated patients had a higher median CHA2DS2-VASc score than those under VKA (5.0 vs. 4.0, p = 0.023). The two primary outcomes showed no statistical differences between the VKAs' group and the NOACs' group (sICH: 5.4 vs. 5.4% [p = 0.911]; mRS at 3 months: 3.0 vs. 3.0 [p = 0.646], respectively).

CONCLUSION:

Preadmission anticoagulation with NOACs in AIS has a functional impact similar to that of VKAs.

KEYWORDS:

Ischaemic stroke; Non-vitamin K antagonists oral anticoagulants; Preadmission anticoagulation therapy; Three months modified Rankin Scale

PMID:
29421803
DOI:
10.1159/000486755
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland
Loading ...
Support Center